Because AR represents a potential therapeutic target in BC and AR positivity may reflect the metastatic potential of tumor cells in some of BC subtypes, the aim of our study was to evaluate the AR status of DTCs in a cohort of early BC patients and compare it with the AR status of the PT. Here, AR is linked to breast cancer.